The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Isomorphic was founded in 2021 as a spin-off from Alphabet's AI research subsidiary, Google ​DeepMind, which is headed by Hassabis. Copyright 2026 Thomson Reuters.

AI in clinical trials is addressing the challenges of escalating data complexity and accelerated timelines. AI in clinical trials is being used to handle increasing complexity, larger volumes of data, ...

Charlie Paterson, partner at PA Consulting, explains how reduced FDA capacity and staff turnover have led to longer regulatory timelines, increased preparation for agency interactions, and delayed ...

Oruka Therapeutics, Inc. announced progress in its clinical programs with ORKA-001 and ORKA-002, targeting chronic skin diseases like psoriasis. The company completed dosing in a Phase 1 trial for ...

CEO Dwight H. Egan reported continued progress on the Co-DX PCR point-of-care platform, stating, "We remain on track to initiate clinical evaluations for all tests in our pipeline during 2025." Egan ...

Efficiency and accelerating clinical trial timelines have emerged as key themes at this year’s annual SCOPE Summit in Orlando, FL. The opening keynote panel of the event moderated by Jeremy Goldberg, ...

In A Nutshell Personalized AI “health agents,” virtual drug trials, and automated compliance tools could quietly speed up ...

AstraZeneca's $15 billion pledge to its China operations highlights the country's advantages. But other regions are also hoping to host more clinical studies.

In a major regulatory reform aimed at accelerating pharmaceutical research and easing compliance, the Union ministry of ...

Site augmentation emerges as a dynamic response to the growing complexity and volume of clinical trials, and the challenge of limited resources at clinical research sites. This support model, which is ...